Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.65 EUR | +0.83% | -1.77% | +96.03% |
30/04 | European Equities Traded in the US as American Depositary Receipts Decline | MT |
30/04 | MorphoSys AG Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+96.03% | 2.7B | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- MOR Stock
- News MorphoSys AG
- MorphoSys : Incyte New Drug Application for Potential Lymphoma Treatment Accepted by Health Canada